The American pharmaceutical and biotechnology company Moderna has initiated a large clinical trial around a vaccine designed to protect people against bird flu, enrolling participants in the United ...

Moderna has begun a large Phase 3 trial of its mRNA-based bird flu vaccine, enrolling about 4,000 adults in the U.S. and U.K., despite losing substantial U.S. government funding last year. The trial, ...

FILE PHOTO: People pose with syringe with needle in front of displayed Moderna logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo April 21 (Reuters) - ...

The first ever avian influenza vaccine recently started trials in the US. This marks a milestone in the prevention of bird ...

Clare Howard was one of the first people to be vaccinated against the bird flu strain The first volunteers in the UK have been immunised with a vaccine to protect against a potential bird flu pandemic ...

The U.S. Food and Drug Administration (FDA) recently informed Moderna that it would not review the company’s application for approval of its new flu vaccine, which is its first using mRNA technology ...

The company said the first participants have already received a shot. HealthDay News — A new effort to prepare for future bird flu outbreaks is moving forward, despite a major funding setback. The ...

Moderna (MRNA) announced on Wednesday that the company has initiated dosing in a Phase 3 trial designed to evaluate its messenger RNA-based bird flu vaccine candidate, mRNA-1018, in the U.S. and U.K.

April 21 (Reuters) - Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine in the U.S. and the UK, marking the first time a pandemic bird flu vaccine made with ...